Latest Catalys Pacific, LLC Stock Portfolio

About Catalys Pacific, LLC and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Catalys Pacific, LLC reported an equity portfolio of $351.4 Millions as of 30 Sep, 2025.

The top stock holdings of Catalys Pacific, LLC are , PHAT. The fund has invested 96.1% of it's portfolio in MINERALYS THERAPEUTICS, INC. and 3.9% of portfolio in PHATHOM PHARMACEUTICALS, INC.

Catalys Pacific, LLC Annual Return Estimates Vs S&P 500

New Buys

No new stocks were added by Catalys Pacific, LLC

Additions

No additions were made to existing positions by Catalys Pacific, LLC

Reductions

None of the existing positions were reduced by Catalys Pacific, LLC

Sold off

None of the stocks were completely sold off by Catalys Pacific, LLC

Sector Distribution

Sector	%
Others	96.1
Healthcare	3.9

Market Cap. Distribution

Category	%
UNALLOCATED	96.1
SMALL-CAP	3.9

Stocks belong to which Index?

Index	%
Others	96.1
RUSSELL 2000	3.9

Top 5 Winners (%)		%
	mineralys therapeutics, inc.	180.3 %
PHAT	phathom pharmaceuticals, inc.	22.7 %

Top 5 Winners ($)		$
	mineralys therapeutics, inc.	217.2 M
PHAT	phathom pharmaceuticals, inc.	2.5 M

Top 5 Losers (%)		%

Top 5 Losers ($)		$

Catalys Pacific, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Catalys Pacific, LLC

Last Reported on: 14 Nov, 2025

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
PHAT	phathom pharmaceuticals, inc.	3.91	1,167,110	13,736,900	unchanged	0.00

	mineralys therapeutics, inc.	96.09	8,903,840	337,634,000	unchanged	0.00